Marija Kundakovic, Ph.D. - Publications

Columbia University, New York, NY 
behavioral/psychiatric epigenetics

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Peter CJ, Fischer LK, Kundakovic M, Garg P, Jakovcevski M, Dincer A, Amaral AC, Ginns EI, Galdzicka M, Bryce CP, Ratner C, Waber DP, Mokler D, Medford G, Champagne FA, et al. DNA Methylation Signatures of Early Childhood Malnutrition Associated With Impairments in Attention and Cognition. Biological Psychiatry. PMID 27184921 DOI: 10.1016/J.Biopsych.2016.03.2100  0.6
2015 Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, ... ... Kundakovic M, et al. The PsychENCODE project. Nature Neuroscience. 18: 1707-1712. PMID 26605881 DOI: 10.1038/Nn.4156  0.6
2015 Akbarian S, Kundakovic M. CHRNA7 and CHRFAM7A: Psychosis and Smoking? Blame the Neighbors! The American Journal of Psychiatry. 172: 1054-6. PMID 26575444 DOI: 10.1176/Appi.Ajp.2015.15081018  0.6
2015 Braithwaite EC, Kundakovic M, Ramchandani PG, Murphy SE, Champagne FA. Maternal prenatal depressive symptoms predict infant NR3C1 1F and BDNF IV DNA methylation. Epigenetics : Official Journal of the Dna Methylation Society. 10: 408-17. PMID 25875334 DOI: 10.1016/J.Psyneuen.2015.07.398  0.6
2015 Morishita H, Kundakovic M, Bicks L, Mitchell A, Akbarian S. Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia. Neurobiology of Learning and Memory. PMID 25849095 DOI: 10.1016/J.Nlm.2015.03.005  0.6
2015 Kundakovic M, Gudsnuk K, Herbstman JB, Tang D, Perera FP, Champagne FA. DNA methylation of BDNF as a biomarker of early-life adversity. Proceedings of the National Academy of Sciences of the United States of America. 112: 6807-13. PMID 25385582 DOI: 10.1073/Pnas.1408355111  0.6
2015 Kundakovic M, Champagne FA. Early-life experience, epigenetics, and the developing brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 141-53. PMID 24917200 DOI: 10.1038/Npp.2014.140  0.6
2014 Kundakovic M. Postnatal risk environments, epigenetics, and psychosis: putting the pieces together. Social Psychiatry and Psychiatric Epidemiology. 49: 1535-6. PMID 24974080 DOI: 10.1007/S00127-014-0927-8  0.6
2014 Kundakovic M. DNA Methyltransferase Inhibitors and Psychiatric Disorders Epigenetics in Psychiatry. 497-514. DOI: 10.1016/B978-0-12-417114-5.00024-3  0.6
2013 Kundakovic M, Lim S, Gudsnuk K, Champagne FA. Sex-specific and strain-dependent effects of early life adversity on behavioral and epigenetic outcomes. Frontiers in Psychiatry. 4: 78. PMID 23914177 DOI: 10.3389/Fpsyt.2013.00078  0.6
2013 Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proceedings of the National Academy of Sciences of the United States of America. 110: 9956-61. PMID 23716699 DOI: 10.1073/Pnas.1214056110  0.6
2013 Kundakovic M. Prenatal programming of psychopathology: The role of epigenetic mechanisms Journal of Medical Biochemistry. 32: 313-324. DOI: 10.2478/jomb-2013-0047  0.6
2012 Kirkbride JB, Susser E, Kundakovic M, Kresovich JK, Davey Smith G, Relton CL. Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics. 4: 303-15. PMID 22690666 DOI: 10.2217/Epi.12.20  0.6
2011 Kundakovic M, Champagne FA. Epigenetic perspective on the developmental effects of bisphenol A. Brain, Behavior, and Immunity. 25: 1084-93. PMID 21333735 DOI: 10.1016/J.Bbi.2011.02.005  0.6
2011 Grayson DR, Kundakovic M, Chen Y, Dong E, Guidotti A. Epigenetic regulation of GABAergic targets in psychiatry Epigenetics and Human Health. 23-40. DOI: 10.1007/978-3-642-17426-1_2  0.6
2010 Grayson DR, Kundakovic M, Sharma RP. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Molecular Pharmacology. 77: 126-35. PMID 19917878 DOI: 10.1124/Mol.109.061333  0.6
2009 Grayson DR, Chen Y, Dong E, Kundakovic M, Guidotti A. From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia. Epigenetics : Official Journal of the Dna Methylation Society. 4: 144-9. PMID 19395859 DOI: 10.4161/Epi.4.3.8534  0.6
2009 Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends in Pharmacological Sciences. 30: 55-60. PMID 19110320 DOI: 10.1016/J.Tips.2008.10.010  0.6
2009 Costa E, Chen Y, Dong E, Grayson DR, Kundakovic M, Maloku E, Ruzicka W, Satta R, Veldic M, Zhubi A, Guidotti A. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Review of Neurotherapeutics. 9: 87-98. PMID 19102671 DOI: 10.1586/14737175.9.1.87  0.6
2009 Kundakovic M, Chen Y, Guidotti A, Grayson DR. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Molecular Pharmacology. 75: 342-54. PMID 19029285 DOI: 10.1124/Mol.108.051763  0.6
2007 Chen Y, Kundakovic M, Agis-Balboa RC, Pinna G, Grayson DR. Induction of the reelin promoter by retinoic acid is mediated by Sp1. Journal of Neurochemistry. 103: 650-65. PMID 17666047 DOI: 10.1111/J.1471-4159.2007.04797.X  0.6
2007 Kundakovic M, Chen Y, Costa E, Grayson DR. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Molecular Pharmacology. 71: 644-53. PMID 17065238 DOI: 10.1124/Mol.106.030635  0.6
2006 Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacology & Therapeutics. 111: 272-86. PMID 16574235 DOI: 10.1016/J.Pharmthera.2005.01.007  0.6
2005 Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. Journal of Neurochemistry. 93: 483-92. PMID 15816871 DOI: 10.1111/J.1471-4159.2005.03040.X  0.6
Show low-probability matches.